Peptilogics

📍 Pittsburgh, United States👥 25 employees💰 Last funded Dec 2020
Biotechnology🌐 peptilogics.com
Website LinkedIn
We are a clinical-stage biotechnology company revolutionizing the discovery and development process for novel peptide therapeutics for patients with serious and life-threatening diseases. Combining the untapped potential of peptide biology with the power of machine learning, we strive to scale our drug design approach and usher in the next generation of peptide therapeutics through precision engineering and design. Our lead peptide therapeutic, PLG0206, is a novel, broad-spectrum anti-infective currently being investigated in clinical studies as a potential treatment for prosthetic joint infection, a historically difficult-to-treat condition with a severe unmet need.
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Peptilogics?
Peptilogics has 1 investors on record on gritt.io.
When did Peptilogics last raise funding?
The most recent investment in Peptilogics recorded on gritt.io was in December 2020.
What industry is Peptilogics in?
Peptilogics operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is Peptilogics based?
Peptilogics is headquartered in Pittsburgh, United States.